Activity from announced rounds
Draper Associates is a global venture firm investing in AI, robotics, blockchain, healthcare, biotechnology, aerospace and other emerging technologies.
Its blockchain thesis includes decentralised finance, tokenised assets and decentralised infrastructure. In healthcare, it focuses on technologies such as AI diagnostics, regenerative medicine and neurotechnology that can improve prevention and healthy lifespan.
The firm also backs automation and human-machine collaboration, alongside space technologies. Founders can submit a pitch directly through its website, which also provides an AI pitch-coaching tool.
Cloverleaf Bio is developing engineered transfer RNA therapies that use a modified tRNA payload to inhibit cancer cells' RNA-modifying enzymes. Its lead program targets liver cancer and is advancing toward clinical testing; a second antibody-tRNA program for colorectal cancer remains preclinical.